Jubilant Pharmova Ltd - 530019 - Completion Of Inspection By USFDA
Completion of inspection by USFDA14-12-2022
14-12-2022
Jubilant Pharmova Ltd - 530019 - Clarification - Letter Dated December 12, 2022
Clarification - Letter dated December 12, 202212-12-2022
Jubilant Pharmova Ltd - 530019 - Clarification sought from Jubilant Pharmova Ltd
The Exchange has sought clarification from Jubilant Pharmova Ltd on December 12, 2022, with reference to Movement in Volume.The reply is awaited.12-12-2022
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication regarding loss of Share Certificates05-12-2022
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Grant of stock options17-11-2022
Jubilant Pharmova Ltd - 530019 - Outcome Of Postal Ballot Held On November 14, 2022
Outcome of Postal Ballot held on November 14, 202214-11-2022
Jubilant Pharmova Ltd - 530019 - Disclosure Of Q2FY23 RPT Transactions
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of the Related Party Transactions in the prescribed format for half year ended September 30, 2022.04-11-2022
Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported as per enclosed intimation letter03-11-2022
Hold Jubilant Pharmova; target of Rs 395: ICICI Direct
ICICI Direct recommended hold rating on Jubilant Pharmova with a target price of Rs 395 in its research report dated October 29, 2022.01-11-2022
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Analyst and Investor Conference Call31-10-2022